CNR1 and melanoma: Most recently, Richtig and colleagues [95] reported a CBD and CBD-THC-mediated reduction in cell viability from different melanoma cell lines by activating the CB1, TRPV1, and PPARα receptors and activating cytochrome c-mediated cell death.